We don’t ring-fence set amounts of money to be spent on particular cancer types – the amount we spend varies from year to year as new research projects start and finish.
Watch this video on the right to find out how we ensure we only fund the best science that stands the best chance of making a difference for people affected by cancer.
What we spent on different cancer types in 2015/16
We spent £376 million on life-saving research carried out in 2015/16, including nearly £120 million into the biology of cancer that underpins the rest of our research. We also set aside money for future work on long-term projects that are running over several years. The total amount we put towards research in 2015/16 was £404 million.
Our 2015/16 spend on research includes £37 million on clinical trials, £29 million on research into new drugs, and £15 million on research into possible causes of cancer, helping people to reduce their risk.
We’re aiming to increase the amount we spend on hard-to-treat cancers as part of our strategy, including pancreatic, lung, oesophageal cancers and brain tumours. We’re also planning to spend more in other areas such as early diagnosis.
We always aim to fund the best quality research with the greatest potential to bring benefits to people affected by all types of cancer.